NVAX

Novavax Inc

8.76

Nov 12 • 3:59 PM ET -1.22 (-12.22%)

8.82

Aftermarket • 5:06 PM ET +0.06 (0.69%)

Healthcare Biotechnology USA Small NASD

Peers: MRNA BNTX ARCT VALN PCVX PFE SNY VIR GSK EBS

| Held by: VTI XBI VB IWM VBK VXF IWN PBE IBB VTWO

Scroll to Statements

Index	RUT
Market Cap	1.45B
Enterprise Value	1.12B
Income	-76.73M
Sales	411.65M
Book/sh	-1.31
Cash/sh	3.77
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	Dec 13, 2007
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	749
IPO	Dec 05, 1995

P/E	-
Forward P/E	-
PEG	-
P/S	3.51
P/B	-
P/C	2.32
P/FCF	-
EV/EBITDA	-
EV/Sales	2.72
Quick Ratio	2.09
Current Ratio	2.15
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	-0.47
EPS next Y	-0.45
EPS next Q	0.54
EPS this Y	-102.00%
EPS next Y	-763.03%
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	-17.24% 18.76%
EPS Y/Y TTM	-121.87%
Sales Y/Y TTM	-61.33%
EPS Q/Q	84.74%
Sales Q/Q	-3.05%
Earnings	Nov 05 BMO
EPS/Sales Surpr.	45.09% 35.45%

Insider Own	4.97%
Insider Trans	0.00%
Inst Own	63.45%
Inst Trans	-0.64%
ROA	-7.42%
ROE	-
ROIC	-99.96%
Gross Margin	78.54%
Oper. Margin	-16.53%
Profit Margin	-18.64%
SMA20	-14.43%
SMA50	-17.15%
SMA200	-6.19%
Trades

Shs Outstand	164.99M
Shs Float	156.81M
Short Float	29.55%
Short Ratio	6.94
Short Interest	46.33M
52W High	13.39 -34.55%
52W Low	6.20 41.29%
Volatility	8.33% 8.34%
ATR (14)	0.89
RSI (14)	38.88
Beta	2.72
Rel Volume	1.05
Avg Volume	6.67M
Volume	6,982,033

Perf Week	-10.43%
Perf Month	-30.70%
Perf Quarter	8.82%
Perf Half Y	-6.31%
Perf YTD	30.36%
Perf Year	21.67%
Perf 3Y	40.38%
Perf 5Y	-94.84%
Perf 10Y	-68.49%
Recom	2.62
Target Price	13.88
Prev Close	9.98
Price	8.76
Change %	-12.22%

Consensus

Hold

Avg. Price Target

$13.88

Implied Upside

+58.4%

Analysts10incl. previous ratings

Rating Distribution5 Buy · 2 Hold · 3 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Oct 24, 2025	Resumed	CCantor Fitzgerald	Overweight	$18	+105.5%
Aug 28, 2025	Resumed	HH.C. Wainwright	Buy	$10	+14.2%
Aug 20, 2025	Downgrade	BBofA Securities	Neutral → Underperform	$7	-20.1%
Jun 17, 2025	Initiated	CCitigroup	Sell	$6	-31.5%
Feb 28, 2025	Initiated	BBTIG Research	Buy	$19	+116.9%
Jul 30, 2024	Downgrade	JJP Morgan	Neutral → Underweight	$8	-8.7%
May 10, 2024	Upgrade	JJP Morgan	Underweight → Neutral
May 10, 2024	Upgrade	BBofA Securities	Underperform → Neutral	$4 → $12	+37.0%
Aug 09, 2023	Upgrade	RB. Riley Securities	Neutral → Buy	$15	+71.2%
Apr 20, 2023	Downgrade	TTD Cowen	Outperform → Market Perform	$55 → $10	+14.2%
Mar 01, 2023	Downgrade	RB. Riley Securities	Buy → Neutral	$29 → $10	+14.2%
Jan 09, 2023	Reiterated	RB. Riley Securities	Buy	$74 → $37	+322.4%
Dec 30, 2022	Reiterated	HH.C. Wainwright	Buy	$207 → $110	+1,155.7%
Dec 02, 2022	Initiated	JJefferies	Hold
Sep 22, 2022	Downgrade	JJP Morgan	Neutral → Underweight	$132 → $27	+208.2%
May 20, 2022	Initiated	BBofA Securities	Underperform	$35	+299.5%
Feb 23, 2022	Reiterated	RB. Riley Securities	Buy	$315 → $265	+2,925.1%
Feb 22, 2022	Resumed	JJefferies	Buy	$198	+2,160.3%
Jan 21, 2022	Initiated	CCowen	Outperform	$150	+1,612.3%
May 12, 2021	Downgrade	JJP Morgan	Overweight → Neutral	$285 → $161	+1,737.9%

Nov-11-26 05:00PM	Novavax to Participate in Jefferies London Healthcare Conference (PR Newswire) -12.22%
Nov-05-26 11:57AM	Novavax Beats On A Narrower Loss And Lifts Its Outlook On Sanofi's $125 Million Milestone, But Its Profitability Target Slides To 2029 (Earnings Whispers) -8.17%
10:38AM	Novavax Raises FY26 Revenue Outlook By 50% Retail Says Licensing Deals Could Create Tremendous Financial Leverage (Stocktwits)
08:07AM	Novavax: Q3 Earnings Snapshot (Associated Press)
08:00AM	Novavax Reports Third Quarter 2026 Financial Results and Operational Highlights (PR Newswire)
05:10AM	Loading…
05:10AM	US Futures Mixed After Rally On Wednesday MU, TSLA, AAPL, MSFT, APP, NVDA, IREN In Focus (Stocktwits)
Oct-29-26 11:57AM	Novavax Heads Into Q3 Report Needing Sanofi Launch Evidence To Justify Its Rally (Earnings Whispers)
09:37AM	Novavax Earns $125 Million Milestone as Sanofi Launches Phase 3 Influenza-COVID-19 Combination Vaccine Trial in Europe (PR Newswire)
08:00AM	Novavax to Report Third Quarter 2026 Financial Results on November 5, 2026 (PR Newswire)
Oct-16-26 05:28PM	Novavax shareholder Shah Capital to step back from activist role (Reuters) -12.17%
03:36PM	Moderna and Novavax Stocks Slump as Biotech's Rally Takes a Breather (Barrons.com)
Oct-12-26 10:23PM	Moderna Stock Soared 14% as NIH Plans COVID-Style Push for Cancer Vaccines (TIKR)
Oct-09-26 08:09PM	BNTX, NVAX, MRNA Lead Vaccine Rally After Report Of An NIH Cancer-Vaccine Push (Stocktwits) +15.80%
04:13PM	Moderna stock hits 4-year high on planned national cancer vaccine effort (Yahoo Finance)
Oct-07-26 06:26AM	Novavax and Moderna Shares Fall as Citi Assesses Vaccine Sector Volatility (InvestorsHub)
05:04PM	Loading…
Oct-06-26 05:04PM	Pandemic Panic Is Back on Wall Street. What to Know About the Russian Plague Scare. (Barrons.com) -9.87%
04:48PM	Novavax, Moderna stocks fall after WHO calls plague risk 'low' (Yahoo Finance)
03:21PM	Novavax Sinks 12% as WHO Calls Plague Risk Very Low (TIKR)
Oct-05-26 11:34PM	NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards' (Stocktwits) +20.08%
07:42PM	NVAX Stock Outruns Moderna As Vaxcytes Shot Clears A Late-Stage Test (Stocktwits)
Sep-02-26 05:00PM	Novavax to Participate in September Investor Conferences (PR Newswire)
Aug-28-26 06:34PM	NVAX Stock Climbs As Partnership Model Keeps COVID Vaccine Cash Flow Open (Stocktwits)
02:42PM	Nvidia Earnings, Warsh Headline Mostly Upbeat Week (Schaeffer's Research)
01:58PM	Pfizer's Updated COVID Shot Ships Into a Smaller Market (GuruFocus.com)
08:30AM	Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season (PR Newswire)
07:59AM	Moderna raises $2.6B to support cancer work; FDA clears updated COVID vaccines (BioPharma Dive)
Aug-26-26 02:48PM	Novavax Stock Pulls Back After Milestone Vaccine Success (Schaeffer's Research)
Aug-19-26 02:54PM	BioNTech Stock Surges 20% on Moderna Cancer Vaccine Win. Why the Gains Could Fade. (Barrons.com) +10.84%
02:46PM	Wall St rises as yields ease, Moderna lifts healthcare stocks (Reuters)
01:37PM	Gold Mining, Drug Stocks Breaking Out Today (Schaeffer's Research)
10:16AM	Loading…
10:16AM	Moderna Stock Eyes Best Day Ever After Cancer Vaccine Breakthrough (Schaeffer's Research)
Aug-06-26 07:19PM	Novavax Inc (NVAX) (Q2 2026) Earnings Call Highlights: Matrix-M Momentum Drives Revenue ... (GuruFocus.com)
05:29PM	NVAX Stock Holds Steady As Novavax Lifts Revenue Outlook On Licensing Pivot Retail Eyes Buyout, More Partnership Deals (Stocktwits)
09:54AM	Novavax tops forecasts and raises revenue outlook as Sanofi collaboration progresses (InvestorsHub)
08:05AM	Novavax: Q2 Earnings Snapshot (Associated Press)
08:00AM	Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights (PR Newswire)
Aug-03-26 04:03PM	NVAX Stock Rises Ahead Of Q2 Earnings As Focus Shifts To Licensing Deals (Stocktwits)
Jul-30-26 07:00AM	Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026 (PR Newswire)
Jun-01-26 04:00PM	Novavax to Participate in 2026 Jefferies Global Healthcare Conference (PR Newswire)
May-11-26 10:54AM	Memory chip stocks hit record highs, pharma reacts to hantavirus concerns (Yahoo Finance Video) -6.03%
May-07-26 04:00PM	Novavax to Participate in BofA Securities 2026 Health Care Conference (PR Newswire) +9.53%
May-06-26 08:08AM	Novavax: Q1 Earnings Snapshot (Associated Press) +15.56%
08:00AM	Novavax Reports First Quarter 2026 Financial Results and Operational Highlights (PR Newswire)
Apr-29-26 04:00PM	Novavax to Report First Quarter 2026 Financial Results on May 6, 2026 (PR Newswire)
Apr-08-26 07:49AM	Activist investor revives campaign to overhaul Novavax board (BioPharma Dive) +5.51%
Mar-30-26 08:00AM	Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development (PR Newswire)
Mar-03-26 09:00AM	Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? (Zacks) -6.13%
Feb-27-26 02:20PM	What's Going On With Novavax Stock On Friday? (Benzinga) -9.38%
12:40PM	Why Novavax (NVAX) Shares Are Falling Today (StockStory)
08:26AM	Novavax Stock Gains as Q4 Earnings & Sales Beat Estimates (Zacks)
06:43AM	Company News for Feb 27, 2026 (Zacks)
12:31AM	NVAX Q4 Deep Dive: Partnership-Led Strategy and Pipeline Transition Shape Outlook (StockStory)
12:07AM	Novavax Q4 Earnings Call Highlights (MarketBeat)
Feb-26-26 04:30PM	Novavax to Participate in Upcoming Investor Conferences (PR Newswire) +17.42%
04:11PM	Novavax Inc (NVAX) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... (GuruFocus.com)
03:55PM	Krispy Kreme stock skyrockets by nearly 30%, Shake Shake rising (Yahoo Finance Video)
02:19PM	COVID-19 Vaccine Maker Novavax Swings To Profit As Sales Climb (Benzinga)
12:15PM	Novavax (NVAX) Beats Q4 Earnings and Revenue Estimates (Zacks)
12:10PM	Why Is Novavax (NVAX) Stock Soaring Today (StockStory)
08:46AM	Novavax shares subdued despite earnings, revenue beat (Investing.com)
08:17AM	Novavax: Q4 Earnings Snapshot (Associated Press Finance)
08:06AM	Novavax (NASDAQ:NVAX) Surprises With Strong Q4 CY2025 (StockStory)
08:00AM	Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights (PR Newswire)
Feb-25-26 06:09AM	Novavax (NVAX) Q4 Earnings Report Preview: What To Look For (StockStory)
Feb-23-26 12:00PM	Novavax (NVAX) Upgraded to Buy: Here's What You Should Know (Zacks)
10:33AM	Nvidia, Joby, CoreWeave, Lucid and More Stocks with Earnings This Week (Benzinga)
09:07AM	What's in Store for These 5 Medical Companies This Earnings Season? (Zacks)
Feb-19-26 08:00AM	Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 (PR Newswire) +6.16%
Feb-17-26 09:00AM	Is Most-Watched Stock Novavax, Inc. (NVAX) Worth Betting on Now? (Zacks)
Feb-11-26 05:45PM	Novavax (NVAX) Rises As Market Takes a Dip: Key Facts (Zacks) -6.13%
Feb-06-26 09:00AM	Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Feb-03-26 05:45PM	Why Novavax (NVAX) Dipped More Than Broader Market Today (Zacks)
Jan-31-26 07:58AM	BofA Notes Positive Interest in Novavax, Inc. (NVAX) Technology Despite Timing Concerns for Licensed Assets (Insider Monkey)
Jan-29-26 08:50AM	This Beaten-Down Biotech Is Showing Signs of Life. Is It a Buy? (Motley Fool)
Jan-28-26 05:45PM	Here's Why Novavax (NVAX) Fell More Than Broader Market (Zacks) -6.01%
03:00AM	Has Novavax cracked the code for survival in the vaccine arena? (Pharma Voice)
Jan-26-26 12:16PM	Novavax Stock Is Surging Monday: What's Driving The Action? (Benzinga) +5.02%
09:00AM	Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jan-22-26 05:45PM	Novavax (NVAX) Stock Dips While Market Gains: Key Facts (Zacks) -5.95%
01:03AM	Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality (Reuters)
Jan-21-26 03:40PM	Why Are Novavax (NVAX) Shares Soaring Today (StockStory) +20.73%
10:06AM	Novavax Grants License for Use of Matrix-M Adjuvant to Pfizer (Zacks)
07:25AM	Pfizer and Novavax ink $530m vaccine delivery licensing deal (Pharmaceutical Technology)
05:38AM	Moderna cancer vaccine holds up; IO Biotech considers a sale (BioPharma Dive)
Jan-20-26 12:53PM	Novavax Pops on Pfizer Licensing Deal (GuruFocus.com)
10:42AM	Novavax Shares Rise After Licensing Deal With Pfizer (Benzinga)
09:59AM	Novavax Licenses Rights to Key Vaccine Component to Pfizer (The Wall Street Journal)
07:15AM	Novavax Announces Entering into a License Agreement with Pfizer (PR Newswire)
Jan-15-26 06:19PM	JPM26: Matrix-M Technology is central to Novavaxs strategy (Pharmaceutical Technology) -5.01%
Jan-14-26 05:45PM	Why Novavax (NVAX) Dipped More Than Broader Market Today (Zacks) -5.54%
08:19AM	Novavax (NVAX) Moves 11.9% Higher: Will This Strength Last? (Zacks)
Jan-13-26 03:23PM	Why Is Novavax Stock Soaring? (Benzinga) +11.87%
09:00AM	Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Jan-12-26 11:27AM	Why Moderna Stock Is Dropping After Good News (Barrons.com) +6.60%
Jan-07-26 08:00AM	Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-05-26 05:45PM	Novavax (NVAX) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jan-04-26 10:39PM	Q3 Earnings Outperformers: Novavax (NASDAQ:NVAX) And The Rest Of The Therapeutics Stocks (StockStory)
Jan-02-26 11:01AM	Novavax (NVAX) Stock Trades Up, Here Is Why (StockStory) +6.10%
Jan-01-26 05:43PM	Novavax (NASDAQ:NVAX) Surprises With Q3 CY2025 Sales (StockStory)
Dec-30-25 09:00AM	Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ruxandra Draghia Akli	Former Officer	May 27 '26	Proposed Sale	11.01	21,383	235,412		May 27 04:42 PM
Ruxandra Draghia Akli	Former Officer	May 07 '26	Proposed Sale	9.87	30,000	296,083		May 07 05:03 PM
Newton Charles W.	Director	Apr 25 '26	Option Exercise	0.00	9,520	0	9,520	Apr 28 05:00 PM
Shiver John W.	Director	Mar 10 '26	Option Exercise	0.00	7,947	0	7,947	Mar 12 05:00 PM
Kelly James Patrick	EVP, CFO and Treasurer	Mar 07 '26	Option Exercise	0.00	12,223	0	136,503	Mar 09 06:13 PM
Kelly James Patrick	EVP, CFO and Treasurer	Mar 03 '26	Option Exercise	0.00	43,167	0	145,130	Mar 05 06:04 AM
Jacobs John C	President and CEO	Mar 03 '26	Option Exercise	0.00	150,167	0	264,130	Mar 05 06:03 AM
O'Hara Elaine	EVP, Chief Strategy Officer	Mar 03 '26	Option Exercise	0.00	56,334	0	157,071	Mar 05 06:02 AM
Casey Mark J	EVP, Chief Legal Officer	Mar 03 '26	Option Exercise	0.00	37,500	0	101,445	Mar 05 06:01 AM
Draghia-Akli Ruxandra	EVP, Research & Development	Mar 03 '26	Option Exercise	0.00	26,667	0	34,876	Mar 05 06:00 AM
Jacobs John C	President and CEO	Mar 01 '26	Option Exercise	0.00	83,333	0	264,130	Mar 03 09:37 PM
Kelly James Patrick	EVP, CFO and Treasurer	Mar 01 '26	Option Exercise	0.00	58,666	0	130,299	Mar 03 09:35 PM
O'Hara Elaine	EVP, Chief Strategy Officer	Mar 01 '26	Option Exercise	0.00	59,600	0	111,706	Mar 03 09:34 PM
Casey Mark J	EVP, Chief Legal Officer	Mar 01 '26	Option Exercise	0.00	4,000	0	65,159	Mar 03 09:33 PM
Jacobs John C	President and CEO	Jan 23 '26	Option Exercise	0.00	83,197	0	219,929	Jan 26 07:57 PM
Casey Mark J	EVP, Chief Legal Officer	Dec 11 '25	Option Exercise	0.00	41,899	0	73,972	Dec 15 04:01 PM

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

PresidentMr. John Charles Jacobs M.B.A.

Executive VPMr. James Patrick Kelly C.F.A.

J.D.Mr. Mark J. Casey Esq.

Executive VP & Chief Strategy OfficerMs. Elaine O'Hara

Executive VP & COOMr. Richard P. Crowley

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

All the Features.Half the Price.

NVAX

Novavax Inc

Upgrade your Finviz experience

All the Features.
Half the Price.